Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06096402
Other study ID # 625668 (REK)
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2024
Est. completion date December 31, 2027

Study information

Verified date October 2023
Source University Hospital of North Norway
Contact Lene Osterballe, MD
Phone +4797572401
Email lene.osterballe@unn.no
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The present proposal aims to asses which is the optimal treatment strategy in a clinical study in patients with paraoesophageal hernia (PEH), a condition often found in elderly, fragile patients The investigator want to study the optimal approach to a paraoesophageal hernia (PEH) repair. The incidence of PEH increases with age and the older patient typically has additional co-morbidities, reduced physiological fitness, and frailty which makes surgery challenging regarding increased morbidity and mortality. Thus, the decision to offer surgery can be challenging in this cohort of patients. The need of an anti-reflux procedure as part of the repair is one of the main subjects for discussion worldwide. To date no consensus exists and many surgical centres do a routine anti-reflux procedure as part of their standard operation for PEH. But is this procedure redundant? Can the patients be managed with a less complicated procedure; an anterior gastropexy with comparable outcome?


Description:

A hiatal hernia is a widening of the diaphragmatic hiatus causing herniation of the stomach into the thoracic cavity. It develops because of an insufficiency of the hiatus. The paraesophageal hernias (PEH) are classified as grade II-IV hiatal hernia with at least 50 % of the stomach misplaced in the thoracic cavity. A paraesophageal hernia (PEH) is a potentially dangerous condition. One see in varied degree, the stomach and other organs being misplaced above diaphragm, in the thoracic cavity. Symptoms such as dysphagia, vomitus, weight loss, pain, short breath and emergent situations where abdominal organs are strangulated with risk of tissue death in thorax defines whether a patient should be offered operation and how fast it should be performed. The operative management of PEH has become a laparoscopic procedure within the last 20-30 years with a concomitant significant decrease in morbidity and length of hospital stay. It is managed by different subspecialized surgeons, all of them having different perspectives and approaches to this condition. Surgery in this area is potentially high-risk operations with risk of perforation of oesophagus, injury to lungs, aorta, pericardia, spleen and stomach. Without operation symptomatic patients with PEH are at risk of developing an acute surgical condition with organ perforation with high per-and postoperative mortality. Contemporary surgical technique is divided into three crucial steps; 1) removal of the hernia sac, 2) hiatoplasty with or without mesh and 3) an anti-reflux procedure and/or gastropexy. Each step is managed differently among surgeons/centres worldwide with varying evidence. Many surgeons add an anti-reflux procedure to the surgical management of PEH, to protect against postoperative acid reflux. The argument is that an anti-reflux procedure lowers postoperative reflux and recurrence of the paraesophageal hernia, but this is without clear evidence. As an addition or an alternative in step three of the PEH procedure, some centres do an anterior gastropexy to anchor the stomach in the abdominal cavity. It is a simple technique compared with an anti-reflux procedure with possibly equal satisfactory long-term outcomes but less postoperative complications. However, evidence is sparse and larger studies on this technique are highly warranted. The aim is to study the need of a fundoplication as part of the procedure for PEH regarding symptom control and quality of life. For this reason, The investigator want to set up a prospective two-armed multicenter study in collaboration with St. Olav's Hospital, Trondheim and Gastroenheden, Hvidovre, Denmark. The reason for this collaboration is 1) to enlarge the group of investigation, as PEH is a rare condition, 2) to compare current practice (fundoplication/no fundoplication) among the included institutions. .


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 220
Est. completion date December 31, 2027
Est. primary completion date December 31, 2026
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Both emergent and elective repair of the paraoesophageal hernia Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
no intervention, but surgical practice as usual is continued. Its a pragmatic study
no intervention

Locations

Country Name City State
Denmark Hvidovre Hospital Copenhagen
Norway University Hospital of North Norway Harstad
Norway St Olavs Hospital Trondheim

Sponsors (3)

Lead Sponsor Collaborator
University Hospital of North Norway Hvidovre University Hospital, St. Olavs Hospital

Countries where clinical trial is conducted

Denmark,  Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary peri- and postoperative complications according to clavien-dindo score 30 days after operation
Primary Gastro-esophageal reflux disease-Health related quality of life, GERD-HRQL The GERD-HRQL questionnaire evaluates heartburn, dysphagia and regurgitation on a scale from zero (no symptoms) to five (severe symptoms) in 15 questions. Maximum score ranges from zero to 75 points Before surgery and 3,6 and 12 months after surgery
Primary Short From questionnaire (SF-36) Health related quality of life SF-36 is a well-established questionnaire consisting of 36 health related questions. Scale is from 0-100 for each section (8 sections) A high score corresponds to a better health status before surgery and 3, 6 and 12 months after surgery
Secondary Total number of patients with radiological recurrence after one year esophagus x-ray/barium swallow one year after surgery one year after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00786084 - Study of Paraesophageal Hernia Repair With Small Intestine Submucosa N/A
Recruiting NCT05974722 - Mesh Vs Pledgets for Repair of Paraesophageal Hernia N/A
Recruiting NCT01799967 - Minimally Invasive Surgery of the Gastro-esophageal Junction
Completed NCT01776827 - Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Completed NCT04436159 - Partial Versus Total Fundoplication in the Surgical Repair of Para-esophageal Hernia. N/A
Completed NCT04007952 - Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair N/A
Recruiting NCT06107634 - Gastropexy in the Repair of Patients With Paraesophageal Hernias N/A
Completed NCT00272922 - Randomized, Prospective Controlled Trial of Paraesophageal Hernia Repair With Small Intestinal Submucosa (SIS) N/A
Active, not recruiting NCT04179578 - The Value of Lateral Release in Reconstruction of the Diaphragmatic Hiatus Hernia N/A
Recruiting NCT05201508 - Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair N/A
Not yet recruiting NCT06193551 - Ovitex in Paraesophageal and Large Hiatal Hernia Repair N/A
Completed NCT01587859 - Short Esophagus in Type II-IV Hiatus Hernia N/A
Completed NCT01606449 - Follow-up of Patients Operated Upon for Type II-IV Hiatal Hernia N/A
Enrolling by invitation NCT05807763 - Fundoplication in Laparoscopic PEH Repair Based on FLIP N/A
Completed NCT03058731 - ACELL Mesh for Paraesophageal Hernia Repair
Completed NCT01099033 - The Biologic Basis of Hernia Formation